Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Anxiety Disorders
  • Anxiety
  • Caffeine
  • Caffeine Abuse
  • Caffeine Dependence
  • Sleep Disorder
  • Insomnia
  • Caffeine Withdrawal
  • Caffeine-Induced Anxiety Disorder
  • Caffeine-Induced Sleep Disorder, Without Use Disorder
  • Caffeine; Sleep Disorder
  • Sleep Disturbance
  • Heartburn
  • Sleep Initiation and Maintenance Disorders
  • Diarrhea
  • Gastrointestinal Dysfunction
Type
Interventional
Phase
Not Applicable
Design
Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Caffeine consumption and secondary measures will be examined before, during, and after the caffeine reduction intervention.Masking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 75 years
Gender
Both males and females

Description

There is emerging evidence that some individuals have difficulty cutting down or eliminating individual's caffeine consumption in spite of clinically significant problems exacerbated by caffeine use. This study will evaluate whether a caffeine reduction program developed at Johns Hopkins can help pe...

There is emerging evidence that some individuals have difficulty cutting down or eliminating individual's caffeine consumption in spite of clinically significant problems exacerbated by caffeine use. This study will evaluate whether a caffeine reduction program developed at Johns Hopkins can help people reduce the caffeine use in an online format. Volunteers will participate in an intervention study conducted entirely online, including video visits for screening, instructions for caffeine reduction, and follow up. The study also involves filling out online surveys sent via email and text message. During screening, participants will be asked questions about participants' personal characteristics including demographic information, weekly caffeine consumption, and general medical history. Participants who are determined to be eligible after screening will complete a session during which participants receive a digital copy of a caffeine reduction manual and instructions on how to gradually cut down caffeine. After this, participants will complete weekly online surveys over six weeks. Participants will complete two follow-up video visits at 7 and 14 weeks after participants received the caffeine reduction instructions. The investigators will measure caffeine consumption over time using the online surveys and interview questions during video visits, and the investigators will also measure how various caffeine related problems may improve during caffeine reduction, such as sleep problems, gastrointestinal issues, and anxiety. During the end of study sessions, participants will answer questions related to acceptability of the online format and report on participants' current caffeine use.

Tracking Information

NCT #
NCT04560595
Collaborators
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Mary M Sweeney, PhD Johns Hopkins University